IMPLANET recently announced the first U.S. surgeries using its ORIGIN cervical plate, acquired from Orthopaedic & Spine Development (OSD) last March.
ORIGIN Cervical Plate Implanted in First U.S. Patients
1 min read Premium comments
Secondary#implanet#origincervicalplate#orthopaedicSpineDevelopment
Synergy with Orthopaedic & Spine Development’s products in the United States is strengthening Implanet’s presence in the U.S., the company said. Implanet is a medical technology company that specializes in vertebral implants.
Phillip Esce, M.D., of Carolina Orthopaedic & Neurosurgical Associates, said: “I regularly use cervical plates in my surgical practice. This new implant was easy and fast to use during the first cases, and the post-operative clinical outcome is highly satisfactory. We will now monitor these patients to confirm the results over the longer term..
Ludovic Lastennet, CEO of IMPLANET, added: “These first implantations are the consequence of the synergies resulting from our merger with OSD, reflecting the advantages of expanding our range of implants for spine surgery. We intend to build on this initial success and intensify our commercial approach, notably in the United States. Our network of agents will now be able to present surgeons with an enhanced range that includes the ORIGIN cervical plate, which has CE marking and FDA clearance. This first step should rapidly lead us to establish our offer on the American market in the field of cervical spine surgery, estimated at $1.35 billion with over 368,000 surgeries.”
Through acquisition of Orthopaedic & Spine Development, Implanet initiated the commercial promotion of the ORIGIN range of anterior cervical plates in the U.S. in late 2020 through OSD’s Boston-based commercial subsidiary.
More than 7,000 ORIGIN plates have sold worldwide since it was first marketed. Having received CE marking in 2009, the ORIGIN cervical plate range was granted 510(k) regulatory clearance from the Food and Drug Administration in the United States in 2020.
IMPLANET has also signed a partnership with Ulrich medical for the distribution of JAZZ implants and ORIGIN cervical plates in Germany. They have also combined products such JAZZ Cap and JAZ PF with OSD’s SAXXO pedicle screw range.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.